NIH-funded research Sbir 2 grant

A new telehealth treatment to help people with acquired brain injury

Official title: RECLAIM A Novel Telehealth Treatment for Acquired Brain Injury

Funded at Posit Science Corporation · NIH-11315643 · Data updated 2026-11-12

A telehealth program using a cognitive training method called Freeze Frame aims to help adults with acquired brain injury who have trouble paying attention and living day-to-day, with FDA-cleared diagnostic support to improve access to care.

More Brain Injury research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionPosit Science Corporation
NIH-funded
Lab location1 site (San Francisco, United States)
Project startAugust 15, 2026
Project endJuly 31, 2028
Funding year2026
Award (this year)$1,048,180
NIH project number1R44NS147449-01
Project IDNIH-11315643 on NIH RePORTER

Who could benefit from this research

Could help

Adults with acquired brain injury, including stroke or traumatic brain injury, who have hemispatial neglect or related attention deficits.

Less likely to help

Patients without neglect or significant attentional deficits may not benefit from this program.

What this research studies

This grant supports developing and delivering a telehealth version of Freeze Frame, a cognitive-control approach that has shown promise for hemispatial neglect after brain injury. It includes work to obtain FDA clearance for a diagnostic assessment used in the program and to integrate a user-friendly telehealth platform so clinicians can diagnose hemineglect efficiently and guide patients to treatment. The project seeks to expand access, improve real-world functioning, and make evidence-based care more available to adults living with ABI and related conditions.

Why it matters

Potential benefit: If successful, patients could receive faster, more accessible treatment for attention and daily functioning problems after brain injury.

How similar studies have gone: Prior trials showed that Freeze Frame improved attention and real-world functioning in people with chronic hemineglect.

Where this research is happening

  • Posit Science Corporation
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Vanvleet, Tom — Posit Science Corporation
  • Study coordinator: Vanvleet, Tom

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.